Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hidetaka Tanaka is active.

Publication


Featured researches published by Hidetaka Tanaka.


Laryngoscope | 2003

Results of Orbital Preservation for Advanced Malignant Maxillary Sinus Tumors

Hiroshi Nishino; Keiichi Ichimura; Hidetaka Tanaka; Kazuhiro Ishikawa; Kouichi Abe; Yoshiro Fujisawa; Takeshi Shinozaki

Objective The purpose of the study was to examine the oncological and functional outcomes of multimodality therapy for patients with advanced malignant maxillary sinus tumors that invaded the orbit.


Journal of Medical Case Reports | 2012

Parotid small cell carcinoma presenting with long-term survival after surgery alone: a case report

Takeharu Kanazawa; Noriyoshi Fukushima; Hidetaka Tanaka; Juntaro Shiba; Hiroshi Nishino; Hiroyuki Mineta; Keiichi Ichimura

IntroductionPrimary involvement of the salivary glands in small cell carcinoma is rare, and has one of the worst prognoses of salivary gland neoplasms. However, it has been reported that some cases have a favorable outcome, although the prognostic factors are still under consideration. Multidisciplinary therapy was usually required to achieve long-term survival. Recently, a resemblance of some small cell carcinomas of the salivary gland to cutaneous Merkel cell carcinoma was suggested; the latter have the potential for spontaneous regression, which is related to a favorable clinical outcome.Case presentationWe present a locoregional advanced parotid small cell carcinoma with multiple lymph node metastases in an 87-year-old Asian woman. The tumor was controlled by surgery alone, and nine-year disease-free survival was achieved without any adjunctive therapy. To the best of our knowledge, this is the longest reported follow-up of head and neck small cell carcinoma.ConclusionWe believe this to be the first case of small cell carcinoma with involvement of the salivary glands reported in the literature with a good outcome after surgery alone without any adjunctive therapy.


Practica oto-rhino-laryngologica | 1999

Surgical Treatment for Squamous Cell Carcinoma of the Lateral Wall of the Oropharynx; A Transoral Approach.

Hiroshi Nishino; Hidetaka Tanaka; Kazuhiro Ishikawa; Takeharu Kanazawa; Kouichi Abe; Masahito Igarashi; Mamoru Miyata; Ken Kitamura; Mamoru Morita

The outcome of radiation therapy or surgery was studied retrospectively in 30 previously untreated patients with squamous cell carcinoma (SCC) of the lateral wall of the oropharynx. Twenty-two patients with tonsillar SCC and 8 patients with tonsillar pillar SCC were treated between 1978 and 1997 at the Jichi Medical School Hospital. The group consisted of 25 men and 5 women, aged 34 to 82 years (average, 63 years). In the tonsillar SCC group, lesions were T1 in 2 cases, T2 in 2, T3 in 13, and T4 in 5; 5, 3, 12 and 2 patients had NO, N1, N2, and N3 disease, respectively. In the tonsillar pillar SCC group, lesions were T2 in 5 cases, T3 in 2, and T4 in 1; 6 patients had NO, 1 had N1, and 1 had N2 disease. Fourteen patients were treated with radiation and 16 were treated with surgery, 14 of whom also received preoperative irradiation. Eleven patients in the surgery group underwent resection by a transoral approach and 5 underwent extended surgery with reconstruction. Disease-free survival rate at 3 years by the Kaplan-Meier method was 64% in the radiation group and 78% in the surgery group (not significantly different) in those with tonsillar SCC, and 67% and 82%, respectively, (not significantly different) in those with tonsillar pillar SCC. The surgical approach was transoral in patients with noninvasive T2 or T3 primary lesions. No local recurrence was observed. Transoral resection appears to be useful for treating noninvasive lateral wall SCC of the oropharynx.


Auris Nasus Larynx | 2006

Nasal dermoplasty for Japanese hereditary hemorrhagic telangiectasia

Keiichi Ichimura; Hidetaka Tanaka; Yoshinori Yamamoto; Kenichi Nakamura


Toukeibu Gan | 2004

RESULTS OF MULTI-MODALITY THERAPY with SURGERY, RADIOTHERAPY, AND REGIONAL CHEMOTHERAPY FOR MALIGNANT MAXILLARY SINUS TUMORS

Hiroshi Nishino; Kazuhiro Ishikawa; Hidetaka Tanaka; Koichi Abe; Takeshi Shinozaki; Yoshiro Fuzisawa; Keiichi Ichimura


Japanese jornal of Head and Neck Cancer | 2002

RESULTS OF TREATMENT OF STAGE III AND IV TONGUE CANCER

Hiroshi Nishino; Takeshi Shinozaki; Yoshiro Fujisawa; Kazuhiro Ishikawa; Hidetaka Tanaka; Kouichi Abe; Keiichi Ichimura


Otology Japan | 1995

Report of Two Cases with Traumatic Perilymph Fistula

Hiroyuki Kakoi; Kazuhiro Ishikawa; Hidetaka Tanaka; Yuya Tamagawa; Ko Inoue; Ken Kitamura; Fumihisa Hiraide


Journal of Japan Society for Head and Neck Surgery | 2008

A case of MALT lymphoma of the larynx

Kenichi Nakamura; Hidetaka Tanaka; Tsuyoshi Shinozaki; Hiroshi Nishino; Keiichi Ichimura


Journal of Japan Society for Head and Neck Surgery | 2007

Study of pharyngocutaneous fistula following total laryngectomy

Takeshi Shinozaki; Hiroshi Nishino; Hideaki Kanazawa; Saeko Ikeda; Koichi Abe; Hidetaka Tanaka; Kazuhiro Ishikawa; Kenichi Nakamura; Keiichi Ichimura


Auris Nasus Larynx | 2006

Acute sensorineural hearing loss and vertigo in a young adult with congenital plasminogen disorder

Takashi Ishida; Ken Kitamura; Hidetaka Tanaka; Keiichi Ichimura; Jun Mimuro; Seiji Madoiwa; Yoichi Sakata

Collaboration


Dive into the Hidetaka Tanaka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ken Kitamura

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuya Tamagawa

Jichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Koichi Abe

Jichi Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge